- Home
- MRVI vs OLMA Comparison
MRVI vs OLMA Comparison
Compare MRVI & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- OLMA
- Stock Information
- Founded
- MRVI 2014
- OLMA 2006
- Country
- MRVI United States
- OLMA United States
- Employees
- MRVI 560
- OLMA N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- MRVI Health Care
- OLMA Health Care
- Exchange
- MRVI Nasdaq
- OLMA Nasdaq
- Market Cap
- MRVI 350.1M
- OLMA 378.9M
- IPO Year
- MRVI 2020
- OLMA 2020
- Fundamental
- Price
- MRVI $2.42
- OLMA $5.46
- Analyst Decision
- MRVI Hold
- OLMA Strong Buy
- Analyst Count
- MRVI 10
- OLMA 5
- Target Price
- MRVI $5.84
- OLMA $24.00
- AVG Volume (30 Days)
- MRVI 1.5M
- OLMA 450.7K
- Earning Date
- MRVI 08-11-2025
- OLMA 08-11-2025
- Dividend Yield
- MRVI N/A
- OLMA N/A
- EPS Growth
- MRVI N/A
- OLMA N/A
- EPS
- MRVI N/A
- OLMA N/A
- Revenue
- MRVI $219,830,000.00
- OLMA N/A
- Revenue This Year
- MRVI N/A
- OLMA N/A
- Revenue Next Year
- MRVI $7.23
- OLMA N/A
- P/E Ratio
- MRVI N/A
- OLMA N/A
- Revenue Growth
- MRVI N/A
- OLMA N/A
- 52 Week Low
- MRVI $1.67
- OLMA $2.86
- 52 Week High
- MRVI $9.60
- OLMA $13.93
- Technical
- Relative Strength Index (RSI)
- MRVI 49.60
- OLMA 54.42
- Support Level
- MRVI $2.28
- OLMA $5.54
- Resistance Level
- MRVI $2.47
- OLMA $5.85
- Average True Range (ATR)
- MRVI 0.14
- OLMA 0.30
- MACD
- MRVI -0.01
- OLMA -0.01
- Stochastic Oscillator
- MRVI 27.45
- OLMA 51.79
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.